# FMC Corp: Form 10-Q for the period ended Sep 30, 2010

- Company: [FMC Corp](/companies/fmc.md) (CIK 37785)
- Form: 10-Q
- Filed: 2010-11-02
- Accepted by EDGAR: Nov 2, 2010, 19:27 ET
- Period: 2010-09-30
- Accession: 0001193125-10-244206
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/37785/000119312510244206/d10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/37785/000119312510244206/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2010-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2010-07-01 to 2010-09-30 | $772.5m | us-gaap:Revenues |
| Revenue | 9 months, 2010-01-01 to 2010-09-30 | $2.31bn | us-gaap:Revenues |
| Cost of revenue | 3 months, 2010-07-01 to 2010-09-30 | $517.8m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months, 2010-01-01 to 2010-09-30 | $1.52bn | us-gaap:CostOfRevenue |
| Selling, general and administrative | 3 months, 2010-07-01 to 2010-09-30 | $99.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2010-01-01 to 2010-09-30 | $286.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2010-07-01 to 2010-09-30 | $127.1m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2010-01-01 to 2010-09-30 | $394.4m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2010-07-01 to 2010-09-30 | $32.3m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2010-01-01 to 2010-09-30 | $106.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2010-07-01 to 2010-09-30 | $82.9m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2010-01-01 to 2010-09-30 | $226.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2010-07-01 to 2010-09-30 | $1.13 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2010-01-01 to 2010-09-30 | $3.08 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2010-07-01 to 2010-09-30 | $1.14 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2010-01-01 to 2010-09-30 | $3.11 | us-gaap:EarningsPerShareBasic |
| Operating cash flow | 9 months, 2010-01-01 to 2010-09-30 | $308.2m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 9 months, 2010-01-01 to 2010-09-30 | $95.3m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2010-01-01 to 2010-09-30 | $27.3m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months, 2010-01-01 to 2010-09-30 | $37.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2010-09-30 | $267.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2010-09-30 | $1.76bn | us-gaap:AssetsCurrent |
| Total assets | at 2010-09-30 | $3.40bn | us-gaap:Assets |
| Current liabilities | at 2010-09-30 | $834.5m | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2010-09-30 | $535.3m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2010-09-30 | $105.4m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2010-09-30 | $1.30bn | us-gaap:StockholdersEquity |
| Shares outstanding | at 2010-09-30 | 72,535,622 shares | dei:EntityCommonStockSharesOutstanding |

## Management's discussion and analysis

As filed, 76,151 characters.

Item 2 of this report contains certain forward-looking statements that are based on our current views and assumptions regarding future events, future business conditions and the outlook for our company based on currently available information.

Whenever possible, we have identified these forward-looking statements by such words or phrases as “will likely result”, “is confident that”, “expects”, “should”, “could”, “may”, “will continue to”, “believes”, “anticipates”, “predicts”, “forecasts”, “estimates”, “projects”, “potential”, “intends” or similar expressions identifying “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words or phrases. Such forward-looking statements are based on our current views and assumptions regarding future events, future business conditions and the outlook for our company based on currently available information. The forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those expressed in, or implied by, these statements. These statements are qualified by reference to the section “Forward-Looking Statements” in Part II of our Annual Report on Form 10-K for the year ended December 31, 2009 (the “2009 10-K”) and to similar disclaimers in all other reports and forms filed with the Securities and Exchange Commission (“SEC”). We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made.

We further caution that the list of risk factors in Item 1A in Part 1 of the 2009 10-K may not be all-inclusive, and we specifically decline to undertake any obligation to publicly revise any forward-looking statements that have been made to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

### APPLICATION OF CRITICAL ACCOUNTING POLICIES

Our consolidated financial statements are prepared in conformity with U.S. generally accepted accounting principles. The preparation of our financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. We have described our accounting policies in Note 1 to our consolidated financial statements included in our 2009 10-K. We have reviewed these accounting policies, identifying those that we believe to be critical to the preparation and understanding of our consolidated financial statements. We have reviewed these critical accounting policies with the Audit Committee of our Board of Directors. Critical accounting policies are central to our presentation of results of operations and financial condition and require management to make estimates and judgments on certain matters. We base our estimates and judgments on historical experience, current conditions and other reasonable factors.

The following is a list of those accounting policies that we have deemed most critical to the presentation and understanding of our results of operations and financial condition. See the “Application of Critical Accounting Policies” section in our 2009 10-K for a detailed description of these policies and their potential effects on our results of operations and financial condition.

- Environmental obligations
- Impairment and valuation of long-lived assets
- Pensions and other postretirement benefits
- Income taxes

We did not adopt any changes in the current period that had a material effect on these critical accounting policies nor did we make any changes to our accounting policies that would have changed these critical accounting policies.

### RECENTLY ISSUED AND ADOPTED ACCOUNTING PRONOUNCEMENTS AND REGULATORY ITEMS

See Note 2 to our condensed consolidated financial statements included in this Form 10-Q for a discussion of recently adopted accounting guidance and other new accounting guidance.

### OVERVIEW

We are a diversified, global chemical company providing innovative solutions, applications and market leading products to a wide variety of markets. We operate in three distinct business segments: Agricultural Products, Specialty Chemicals and Industrial Chemicals. Our Agricultural Products segment develops, markets and sells all three major classes of crop protection chemicals – insecticides, herbicides, and fungicides – with particular strength in insecticides and herbicides. These products are used in agriculture to enhance crop yield and quality by controlling a broad spectrum of insects, weeds and disease, as well as pest control in non-agricultural markets. Specialty Chemicals consists of our BioPolymer and Lithium businesses and focuses on food ingredients that are used to enhance texture, structure and physical stability, pharmaceutical additives for binding, encapsulation and disintegrant applications, ultrapure biopolymers for medical devices and lithium specialties for pharmaceutical synthesis, specialty polymers and energy storage. Our Industrial Chemicals segment manufactures a wide range of inorganic materials, including soda ash, hydrogen peroxide, specialty peroxygens and phosphorus chemicals.

### 2010 Year To Date Highlights

Our businesses this year have been positively impacted by the increase in global economic activity resulting in higher volumes. Results for the nine months ended September 30, 2010, reflect increases in both consolidated revenues and earnings driven by solid performance in all three of our operating segments.

Our Agricultural Products segment revenues increased 16 percent year to date, driven by sales gains in North America, Latin America, particularly Brazil, and Asia due to improved market conditions in several key crops and growth from new and recently introduced products. Revenue also increased in our Specialty Chemicals segment with revenues up 11 percent compared to the prior year period. Revenue increases in the Specialty Chemicals segment were led by a robust demand recovery in lithium primaries and strong commercial performance in BioPolymer. Our Industrial Chemicals segment revenues increased two percent from the year-ago period as volume gains across all businesses were largely offset by reduced selling prices and lower electricity sales stemming from the sale of a Spanish cogeneration facility in 2009.

Agricultural Products operating profit increased two percent compared to the prior year period reflecting strong sales performance partially offset by less favorable mix, higher inventory and distribution costs, increased selling and administrative expenses and higher spending on growth initiatives. Specialty Chemicals operating profit grew by 16 percent as volume gains in lithium primaries, favorable commercial performance in BioPolymer and the benefits of productivity initiatives were partially offset by higher raw material costs. Industrial Chemicals operating profit increased 65 percent from the prior year period, driven by the strong demand recovery and lower raw material, particularly phosphate rock, and energy costs which more than offset lower selling prices across the segment.

### RESULTS OF OPERATIONS

### Overview

The following presents a reconciliation of our segment operating profit to net income attributable to FMC stockholders as seen through the eyes of our management. For management purposes, we report the operating performance of each of our business segments based on earnings before interest and income taxes excluding corporate expenses, other income (expense), net and corporate special income/(charges).

*(in Millions)*

| Revenue | Three Months Ended September 30, 2010 | 2009 | Nine Months Ended September 30, 2010 | 2009 |
| --- | ---: | ---: | ---: | ---: |
| Agricultural Products | $308.9 | $268.3 | $907.3 | $782.1 |
| Specialty Chemicals | 202.2 | 191.7 | 619.4 | 558.9 |
| Industrial Chemicals | 262.4 | 254.4 | 781.7 | 766.6 |
| Eliminations | (1.0) | (1.1) | (2.6) | (3.5) |
| Total | $772.5 | $713.3 | $2,305.8 | $2,104.1 |
| **Income (loss) from continuing operations before income taxes** |  |  |  |  |
| Agricultural Products | $75.1 | $59.2 | $247.5 | $242.2 |
| Specialty Chemicals | 47.1 | 40.9 | 139.0 | 119.5 |
| Industrial Chemicals | 30.0 | 20.7 | 94.3 | 57.0 |
| Eliminations | 0.1 | — | 0.2 | (0.1) |
| **Segment operating profit (1)** | 152.3 | 120.8 | 481.0 | 418.6 |
| Corporate | (15.9) | (10.3) | (42.9) | (31.9) |
| Other income (expense), net | (7.6) | (8.3) | (15.3) | (21.1) |
| Interest expense, net | (9.6) | (6.2) | (29.0) | (19.7) |
| Corporate special income (charges): |  |  |  |  |
| Restructuring and other income (charges) | (3.7) | (32.3) | (35.7) | (84.9) |
| Purchase accounting inventory fair value impact and other related inventory adjustments | — | (2.4) | — | (4.7) |
| Provision for income taxes | (32.3) | (27.2) | (106.8) | (74.2) |
| Discontinued operations, net of income taxes | (0.3) | (6.1) | (25.3) | (15.7) |
| **Net income attributable to FMC stockholders** | $82.9 | $28.0 | $226.0 | $166.4 |

(1) Results for all segments are net of noncontrolling interests of $3.0 million and $9.2 million in the three and nine months ended September 30, 2010, respectively and $1.4 million and $5.6 million in the three and nine months ended September 30, 2009, respectively. The majority of these noncontrolling interests pertain to our Industrial Chemicals segment.

The following chart, which is provided to assist the readers of our financial statements, depicts certain after-tax charges (gains). These items are excluded by us in the measures we use to evaluate business performance and determine certain performance-based compensation. These after-tax items are discussed in detail within the “Other results of operations” section that follows. Additionally, the chart below discloses our Non-GAAP financial measure “After-tax income from continuing operations, excluding restructuring and other income and charges” reconciled from the GAAP financial measure “Net income attributable to FMC stockholders”. We believe that this measure provides useful information about our operating results to investors and securities analysts. We also believe that excluding the effect of restructuring and other income and charges from operating results allows management and investors to compare more easily the financial performance of our underlying businesses from period to period. This measure should not be considered as a substitute for net income (loss) or other measures of performance or liquidity reported in accordance with GAAP.

*(in Millions)*

|  | Three Months Ended September 30, 2010 | 2009 | Nine Months Ended September 30, 2010 | 2009 |
| --- | ---: | ---: | ---: | ---: |
| **Net income attributable to FMC stockholders** | $82.9 | $28.0 | $226.0 | $166.4 |
| Corporate special charges (income), pre-tax | 3.7 | 34.7 | 35.7 | 89.6 |
| Income tax expense (benefit) on Corporate special charges (income) | (1.1) | (3.8) | (12.0) | (21.6) |
| Corporate special charges (income), net of income taxes | 2.6 | 30.9 | 23.7 | 68.0 |
| Discontinued operations, net of income taxes | 0.3 | 6.1 | 25.3 | 15.7 |
| Tax adjustments | (2.3) | 0.3 | 0.7 | (14.9) |
| **After-tax income from continuing operations excluding restructuring and other income and charges** | $83.5 | $65.3 | $275.7 | $235.2 |

### Three months ended September 30, 2010 compared to Three months ended September 30, 2009

In the discussion below, please refer to our chart on page 31 under “Overview”. All comparisons are between the periods unless otherwise noted.

### Segment Results

For management purposes, segment operating profit is defined as segment revenue less operating expenses (segment operating expenses consist of costs of sales and services, selling, general and administrative expenses and research and development expenses). We have excluded the following items from segment operating profit: corporate staff expense, interest income and expense associated with corporate debt facilities and investments, income taxes, gains (or losses) on divestitures of businesses, restructuring and other charges (income), investment gains and losses, loss on extinguishment of debt, asset impairments, Last-in, First-out (LIFO) inventory adjustments, amortization of inventory step-up from business acquisitions and other related inventory adjustments, and other income and expense items.

Information about how each of these items relate to our businesses at the segment level is discussed in Note 18 of our condensed consolidated financial statements filed in this Form 10-Q and in Note 19 of our 2009 consolidated financial statements in our 2009

10-K.

### Agricultural Products

*(in Millions)*

|  | Three Months Ended September 30, 2010 | 2009 | Increase/(Decrease) $% |  |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $308.9 | $268.3 | $40.6 | 15% |
| Operating Profit | 75.1 | 59.2 | 15.9 | 27 |

Revenue of $308.9 million increased approximately 15 percent versus the prior year quarter, as higher sales were recognized in all regions. North America revenue of $45.4 million increased 16 percent due to strong demand in the cotton market partially offset by weak pest pressure in the crop rescue market. Latin America revenue of $173.9 million increased 12 percent driven by improved market conditions, particularly in Brazil’s sugarcane and cotton markets, and growth in planted acres for key crops. Revenue in Asia of $54.6 million increased 33 percent reflecting improved market conditions, the introduction of new products and favorable currency impacts. Europe revenue of $35.0 million increased eight percent driven primarily by higher herbicide sales and a shift in sales from the second quarter due to the delayed growing season compared to the prior year.

Agricultural Products’ operating profit of $75.1 million increased approximately 27 percent compared to the year-ago quarter, reflecting sales gains and favorable product and geographic mix partially offset by increased spending on new product introductions and growth initiatives.

### Specialty Chemicals

*(in Millions)*

|  | Three Months Ended September 30, 2010 | 2009 | Increase/(Decrease) $% |  |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $202.2 | $191.7 | $10.5 | 5% |
| Operating Profit | 47.1 | 40.9 | 6.2 | 15 |

Revenue in Specialty Chemicals was $202.2 million, an increase of approximately five percent versus the prior-year quarter. The increase was driven primarily by the continued demand recovery in lithium primaries, higher volumes and selling prices in lithium specialties and volume growth in BioPolymer.

BioPolymer revenue of $151.9 million increased three percent from the prior-year quarter. This increase was due to higher volumes which increased revenue by six percent. BioPolymer experienced broad-based volume gains across both food and pharmaceutical markets. This was partially offset by the impact of a weaker euro which had an unfavorable impact on revenue of three percent.

Lithium revenue of $50.3 million increased 14 percent from the prior-year quarter primarily due to higher volumes driven by improving economic conditions slightly offset by lower pricing. The improving economic conditions in lithium are driven primarily by growth in battery, metals and polymer markets in Asia.

Segment operating profit of $47.1 million increased 15 percent versus the year ago quarter, driven by the sales gains, favorable mix in BioPolymer’s food ingredients business and continuous productivity improvements, partially offset by higher raw material costs.

### Industrial Chemicals

*(in Millions)*

|  | Three Months Ended September 30, 2010 | 2009 | Increase/(Decrease) $% |  |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $262.4 | $254.4 | $8.0 | 3% |
| Operating Profit | 30.0 | 20.7 | 9.3 | 45 |

Revenue in Industrial Chemicals was $262.4 million, an increase of approximately three percent versus the prior-year quarter. An increase in volumes across the segment increased revenues by five percent which was partially offset by a two percent decline in pricing. Soda ash revenues were up due to increased volumes, particularly in the export market, partially offset by lower prices. Soda ash volumes continued to rebound significantly from prior year. In our domestic market, our volume growth is in line with the demand recovery being experienced in flat glass, detergents and chemicals. In the export markets, demand is robust, especially in Asia and Latin America. The segment also experienced volume increases in peroxygens offset by reduced selling prices.

Segment operating profit of $30.0 million increased approximately 45 percent versus the year ago quarter as a result of the volume gains, lower raw material and energy costs and lower plant outage costs.

### Other Results of Operations

#### Corporate expenses

We recorded expenses of $15.9 million in the third quarter of 2010 compared to $10.3 million in third quarter of 2009. The increase was primarily due to increased incentive compensation and consulting expenses in the third quarter of 2010 compared to the same period in 2009. The increase in consulting expenses is a result of several new initiatives, primarily involving global procurement, aimed at reducing the costs of goods and services purchased on a world-wide basis. Corporate expenses are included as a component of the line item “Selling, general and administrative expenses” on our condensed consolidated statements of income.

#### Other income (expense), net

Other income (expense), net is comprised primarily of last-in, first-out (“LIFO”) inventory adjustments and pension expense. Other expense decreased to $7.6 million in the third quarter of 2010 from $8.3 million in the same period of 2009. The decrease was due primarily to income related to a decrease in our LIFO inventory reserves partially offset by higher pension expense. Excluding pension expense, other income (expense), net is included as a component of the line item “Costs of sales and services” on our condensed consolidated statements of income. Pension expense is included as a component of the line item “Selling, general and administrative expenses” on our condensed consolidated statements of income.

#### Interest expense, net

Interest expense, net for the third quarter of 2010 was $9.6 million as compared to $6.2 million in the third quarter of 2009. The increase was due to higher interest rates associated with our senior notes bond offering in the fourth quarter of 2009 whose proceeds were used to pay off lower variable rate debt under our committed credit facilities.

#### Corporate special income (charges)

*Restructuring and other charges (income)* totaled $3.7 million in the third quarter of 2010 compared to $32.3 million in the third quarter of 2009. Please see the table and further discussion regarding our restructuring and other charges (income) in Note 7 to our condensed consolidated financial statements included in this Form 10-Q. Charges (income) in this category for the quarter ended September 30, 2010, include the following:

#### Restructuring charges and asset impairments

- A $1.0 million charge in our Industrial Chemicals segment due to our decision in 2009 to phase out operations of our Barcelona, Spain facility.
- A $0.7 million of other net charges primarily related to adjustments to previously recorded restructuring reserves.

#### Other charges (income), net

- Corporate net charges of $1.3 million relating to environmental remediation at operating sites.
- $0.7 million of other net charges primarily representing charges associated with a collaboration and license agreement in our Agricultural Products segment and the accrual of interest associated with a European Commission fine currently being appealed.

The restructuring and other charges (income) of $32.3 million recorded in the third quarter of 2009 were a result of the following:

#### Restructuring charges and asset impairments

- A $3.6 million charge in our Specialty Chemicals segment due to the realignment of our BioPolymer alginates manufacturing operations. The charge consisted of (i) accelerated depreciation on fixed assets to be abandoned of approximately $3.2 million and (ii) severance and employee benefits of $0.4 million.
- A $5.5 million charge in our Industrial Chemicals segment due to our decision to phase out operations of our Barcelona, Spain facility. The charge consisted of accelerated depreciation on fixed assets to be abandoned of $7.7 million offset by a $2.2 million benefit due to a reduction in our estimated severance and employee benefits for the shutdown that had been accrued in the second quarter of 2009.
- $7.1 million of severance costs due to other workforce restructurings, of which $5.8 million related to our Industrial Chemicals segment and $1.3 million related to our Specialty Chemicals segment.
- Other asset abandonment charges of $1.7 million, of which $1.1 million related to our Industrial Chemicals segment and $0.6 million related to our Specialty Chemicals segment.
- $0.4 million of other charges primarily related to adjustments to previously recorded restructuring reserves.

#### Other charges (income), net

- A $2.3 million net gain as a result of exiting our lease at our Princeton facility.
- A gain of $1.0 million as a result of the sale of our sodium sulfate co-generation facility.
- A charge of $21.0 million related to the resolution of a regulatory matter in our Industrial Chemicals segment.
- A corporate net gain of $4.9 million representing recoveries partially offset by charges relating to environmental remediation at operating sites.
- A $1.0 million charge related to our Agricultural Products segment acquiring further rights under a collaboration and license agreement with a third-party company.
- $0.2 million of other net charges, primarily relating to the accrual of interest associated with a European Commission fine currently being appealed and adjustments related to previously recorded restructuring reserves.

*Purchase accounting inventory fair value impact and other related inventory adjustments* for the three months ended September 30, 2009, represents inventory adjustments related to the third quarter 2008 acquisition in our Specialty Chemicals segment and subsequent alginates business restructuring. On the condensed consolidated statements of income these charges are included in “Costs of sales and services” for the three months ended September 30, 2009. No such event occurred in the three months ended September 30, 2010.

#### Provision for income taxes

We recorded a provision of $32.3 million for the third quarter of 2010 compared to a provision of $27.2 million for the prior year period resulting in effective tax rates of 27.3 percent and 43.4 percent, respectively. The change in the effective tax rate was a result of a charge in 2009 related to the resolution of a regulatory matter in our Industrial Chemicals segment that is nondeductible for tax purposes. No such event occurred in the three months ended September 30, 2010. The change in the effective tax rate was also impacted by a reduction in our liability of $2.5 million for unrecognized tax benefits due to settlements of audits and expiration of statute of limitations. A change in the mix of domestic income compared to income earned outside of the U.S. also impacted the effective tax rate. Income we earn domestically is typically taxed at rates higher than income earned outside the U.S.

#### Discontinued operations, net of income taxes

Our discontinued operations represent adjustments to retained liabilities primarily related to operations discontinued between 1976 and 2001. The primary liabilities retained include environmental liabilities, other post-retirement benefit liabilities, self-insurance and long-term obligations related to legal proceedings.

Discontinued operations, net of income taxes totaled a loss of $0.3 million for the three months ended September 30, 2010, compared to a loss of $6.1 million for the three months ended September 30, 2009. The loss for the three months ended September 30, 2010, primarily related to an increase in our reserve for operating and maintenance activities and charges for legal reserves and expenses related to discontinued operations partially offset by income from an adjustment associated with a tax matter related to a previously discontinued operation.

The loss for the three months ended September 30, 2009, primarily related to environmental charges to increase our reserve for operating and maintenance activities and charges for legal reserves and expenses related to discontinued operations partially offset by recoveries related to our Front Royal site.

#### Net income attributable to FMC stockholders

Net income attributable to FMC stockholders increased to $82.9 million for the three months ended September 30, 2010, from $28.0 million for the three months ended September 30, 2009. The increase was primarily due to higher operating profits in all three of our segments and significantly lower restructuring and other charges (income). Partially offsetting this was an increase in corporate expenses and higher interest expense.

### Nine months ended September 30, 2010 compared to Nine months ended September 30, 2009

In the discussion below, please refer to our chart on page 31 under “Overview”. All comparisons are between the periods unless otherwise noted.

### Segment Results

### Agricultural Products

*(in Millions)*

|  | Nine Months Ended September 30, 2010 | 2009 | Increase/(Decrease) $% |  |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $907.3 | $782.1 | $125.2 | 16% |
| Operating Profit | 247.5 | 242.2 | 5.3 | 2 |

Revenue of $907.3 million increased approximately 16 percent versus the prior year, as higher sales were recognized in North America, Europe, Latin America and Asia. North America crop sales increased 12 percent to $226.7 million due to strong demand for our proprietary herbicides, growth from new and recently introduced products, particularly our newly acquired herbicide, fluthiacet-methyl, and improving market conditions in some non-crop segments. Revenue in Europe of $140.5 million increased nine percent driven primarily by growth from new products, increased herbicide sales and favorable currency impacts primarily in the first quarter. Latin America revenue of $390.6 million increased 18 percent due to improved market conditions, particularly in the sugarcane and cotton segments, and growth in new and recently introduced products. Revenue in Asia increased 23 percent to $149.5 million reflecting better market conditions, the introduction of new products and growth in most countries particularly India, Indonesia, Australia and China.

Agricultural Products’ operating profit of $247.5 million increased two percent compared to the prior year period, reflecting strong sales performance partially offset by less favorable mix, higher inventory and distribution costs, increased selling and administrative expenses and higher spending on growth initiatives.

In 2010, full-year revenue growth of approximately 15 percent is expected, driven by increased volumes in most regions due to gradually improving market conditions and growth in new and recently introduced products. Full-year segment operating profit is expected to be up in the mid-single digits reflecting sales gains partially offset by higher first half inventory costs, increased selling and administrative expenses and higher spending on growth initiatives.

#### Certain Regulatory Issues

In our Agricultural Products segment, several products are undergoing re-registration in the U.S. and/or a comparable regulatory review by the European Union (“EU”) governmental authorities. In August 2006, the U.S. Environmental Protection Agency issued its “Interim Reregistration Eligibility Decision” (“IRED”) for our carbofuran insecticide. The IRED proposed cancellation of all carbofuran uses in the United States, subject to a phase out period for certain minor crop uses while maintaining tolerances for imported commodities (bananas, coffee, rice and sugarcane). The EPA reiterated its proposal in January 2008 with the issuance of a draft Notice of Intent to Cancel. In February 2008, the EPA convened a Scientific Advisory Panel meeting to evaluate scientific issues relevant to the draft Notice of Intent to Cancel carbofuran. Separately, the U.S. Department of Agriculture issued its comments on the draft cancellation notice, stating that carbofuran should continue to be registered. On July 24, 2008, the EPA published a proposal to revoke all carbofuran tolerances under the Federal Food Drug and Cosmetic Act in advance of any issuance of a final Notice of Intent to Cancel under the federal pesticide law. We responded to that notice, expressing our strong disagreement with the EPA’s proposal to revoke tolerances and our belief that carbofuran residues on food do not pose a threat to human health. In May 2009, the EPA published its final revocation of all carbofuran tolerances effective December 31, 2009. We filed our objections to this revocation and requested a hearing before an administrative law judge. On October 30, 2009, EPA issued its decision to deny our objections and request for a hearing. We believe that we are entitled to a hearing and we have challenged this decision by seeking judicial review in the U.S. federal courts. The Court of Appeals granted expedited review of our case and decided the case on July 23, 2010. The Court ruled that EPA acted arbitrarily and capriciously in revoking the import tolerances, and ordered that those tolerances be reinstated. However, the Court did not extend its rationale to the domestic tolerances and instead ruled that EPA had the right to deny our request for administrative hearing. We are reviewing our options regarding this portion of the Court’s decision, which at this point would be filing a petition for writ of certiorari before the U.S. Supreme Court. In light of the December 31, 2009 tolerance revocation, FMC has now ceased sales of carbofuran in the United States. FMC’s sales of carbofuran in the United States are not significant and termination of such U.S. sales will not have a material effect on the Company’s financial condition or results of operations. We do not know the EPA’s timing on a final Notice of Intent to Cancel the carbofuran registration, though the EPA has said it intends to issue such notice after the tolerance revocation decision is finally resolved.

In June 2007, the European Commission published its decisions not to include carbofuran and carbosulfan on the official list of active ingredients approved for continued sale in the EU. The published decisions required EU Member States to de-register the products within six months, and so FMC ceased its sales of these products in December 2007. We disagreed with the Commission’s decisions and underlying assessment. We re-submitted both carbofuran and carbosulfan for approval on the official list. While we still believe both products meet relevant safety criteria upon due consideration of our European strategy including our plans to substitute the most significant EU carbofuran uses with other FMC products and/or applications, we have subsequently decided not to continue pursuing the carbofuran and carbosulfan resubmissions. Termination of such EU sales will not have a material effect on the Company’s financial condition or results of operations.

Also in the EU, in March 2009 the Commission proposed not to include our pyrethroid insecticide bifenthrin on the official list, but the Standing Committee rejected that proposal. The regulatory decision was referred to the EU Council of Ministers. In July 2009, the process concluded whereby the Commission’s non-inclusion proposal will now be implemented. The non-inclusion decision was adopted on November 30, 2009. FMC had an additional six months to sell bifenthrin (i.e., through end-May 2010), and subsequently, in most countries, there is up to 6-12 months for further sale by distributors or dealers and use by farmers. Accordingly, there was no material sales impact in 2010. We have re-submitted for reconsideration and will seek to minimize any interruption in sales.

We intend to defend vigorously all our products in the U.S., EU and other countries’ regulatory processes where FMC’s pesticide products will be reviewed in the ordinary course of regulatory programs during 2010 as part of the ongoing cycle of re-registration in countries around the world. The Brazilian health surveillance agency has informed us that they intend to review carbofuran along with 13 other major pesticides, but has yet to issue any required formal announcement that identifies their specific concerns or preliminary position on re-registration. FMC is cooperating and defending our product in this process. Under the Brazilian regulatory process, any recommendation would need public notice and comment as well as concurrence from the Brazilian environmental and agricultural ministries before any regulatory change is effective. Thus, we do not expect a potential sales impact in 2010.

### Specialty Chemicals

*(in Millions)*

|  | Nine Months Ended September 30, 2010 | 2009 | Increase/(Decrease) 2010 | 2009 |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $619.4 | $558.9 | $60.5 | 11% |
| Operating Profit | 139.0 | 119.5 | 19.5 | 16 |

Revenue in Specialty Chemicals was $619.4 million, an increase of approximately 11 percent versus the prior-year period. The increase was driven primarily by a robust demand recovery in lithium primaries and strong commercial performance in BioPolymer.

BioPolymer revenues of $462.5 million increased seven percent from the prior-year period. This increase was primarily due to higher volumes which increased revenue by six percent. BioPolymer experienced broad-based volume gains across both food and pharmaceutical markets. Additionally, improved pricing and mix increased revenue by three percent, driven primarily by higher pricing in food ingredients.

Lithium revenues of $156.9 million increased 23 percent from the prior-year period primarily due to higher volumes driven by improving economic conditions slightly offset by lower pricing. The improving economic conditions in lithium are driven primarily by growth in battery and metals markets in Asia.

Segment operating profit of $139.0 million increased 16 percent versus the year ago period, as volume gains in lithium primaries, favorable commercial performance in BioPolymer and the benefits of productivity initiatives were partially offset by higher raw material costs.

In 2010, full-year revenue growth of approximately 10 percent is expected, driven by volume growth across BioPolymer markets and lithium primaries, augmented by higher BioPolymer selling prices. Full-year segment operating profit is expected to be up 20 percent, reflecting higher volumes in lithium primaries, strong commercial performance in BioPolymer and continued productivity improvements.

### Industrial Chemicals

*(in Millions)*

|  | Nine Months Ended September 30, 2010 | 2009 | Increase/(Decrease) 2010 | 2009 |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $781.7 | $766.6 | $15.1 | 2% |
| Operating Profit | 94.3 | 57.0 | 37.3 | 65 |

Revenue in Industrial Chemicals was $781.7 million, an increase of approximately two percent versus the prior-year period. An increase in volumes across the segment increased revenues by 10 percent which was offset by a nine percent decline in pricing. Soda ash revenues were up due to increased volumes, particularly in the export market, partially offset by lower prices. The segment experienced volume increases in peroxygens and phosphates offset by reduced selling prices for these products. The segment was also negatively impacted due to lower electricity sales due to the divestiture of a Spanish co-generation facility in the third quarter of 2009. In Spain, we operate electricity co-generation facilities and sell excess electricity into the Spanish electrical grid.

Segment operating profit of $94.3 million increased approximately 65 percent versus the year ago period, driven by the strong demand recovery and lower raw material, particularly phosphate rock, and energy costs which more than offset lower selling prices across the segment.

In 2010, full-year revenue is expected to be level to prior year as stronger volumes in every business are offset by reduced selling prices and unfavorable currency translation. Full-year segment operating profit is expected to be up 35 percent as volume growth and favorable raw material and energy costs are partially offset by lower selling prices.

We continue to pursue strategic alternatives for our Foret phosphorus business in Huelva, Spain which has been inconsistently profitable over the past few years due to volatile phosphorus rock costs and energy pricing from our cogeneration operations. In addition, government restrictions on storing the phosphogypsum on an adjacent site make the future viability of the business uncertain. The phosphogypsum is a byproduct of the process we use to manufacture phosphoric acid, which is used in the manufacture of our phosphate products at the site. We are currently reviewing our options for the phosphorus business. The option selected will determine the magnitude of any charge to be incurred.

### Other Results of Operations

#### Corporate expenses

We recorded expenses of $42.9 million in the first nine months of 2010 compared to $31.9 million in the first nine months of 2009. The increase was primarily due to increased incentive compensation and consulting expenses in the first nine months of 2010 compared to the same period in 2009. The increase in consulting expenses is a result of several new initiatives, primarily involving global procurement, aimed at reducing the costs of goods and services purchased on a world-wide basis.

#### Other income (expense), net

Other expense decreased to $15.3 million in the first nine months of 2010 from $21.1 million in the same period of 2009. The decrease was due primarily to income related to a decrease in our LIFO inventory reserves and the mark to market impact of our deferred compensation liability. These charges were partially offset by higher pension expense and incentive compensation.

#### Interest expense, net

Interest expense, net for the first nine months of 2010 was $29.0 million as compared to $19.7 million in the first nine months of 2009. The increase was due to higher interest rates associated with our senior notes bond offering in the fourth quarter of 2009 whose proceeds were used to pay off lower variable rate debt under our committed credit facilities.

#### Corporate special income (charges)

*Restructuring and other charges (income)* totaled $35.7 million in the nine months ended September 30, 2010, compared to $84.9 million in the nine months ended September 30, 2009. Please see the table and further discussion regarding our restructuring and other charges (income) in Note 7 to our condensed consolidated financial statements included in this Form 10-Q. Charges (income) in this category for the nine months ended September 30, 2010, include the following:

#### Restructuring charges and asset impairments

- A $6.1 million charge in our Specialty Chemicals segment due to the continued realignment of our BioPolymer alginates manufacturing operations. The charge consisted of (i) accelerated depreciation on fixed assets to be abandoned of $0.7 million, (ii) a reduction to previously recorded severance reserves of $0.6 million, (iii) the accrual of costs associated with leased properties which we have ceased using of $5.2 million and (iv) other shut down charges of $0.8 million.
- In 2009, we made the decision to close our Bayport butyllithium facility located in Bayport, Texas, which is part of our Specialty Chemicals segment. We recorded $1.1 million of income which consisted of (i) a reduction of previously recorded retirement obligations at the site of $0.9 million and (ii) a reduction of previously recorded severance reserves of $0.2 million.
- A $10.6 million charge in our Industrial Chemicals segment due to our decision in 2009 to phase out operations of our Barcelona, Spain facility. The charge consisted of (i) accelerated depreciation on fixed assets to be abandoned of $10.1 million, (ii) a reduction to previously recorded severance reserves of $0.2 million and (iii) other shut down costs of $0.7 million.
- In 2009, we made the decision to shut down our manufacturing operations at our Peroxygens facility in Santa Clara, Mexico, which is part of our Industrial Chemicals segment. In the second quarter of 2010, we recorded $1.1 million of income which related to the reversal of a previously recorded loss contingency.
- Severance costs due to other workforce restructurings of $2.3 million primarily related to our Industrial Chemicals segment.
- A $0.9 million gain related to foreign currency translation adjustment as a result of the liquidation of a legal entity that owned a co-generation facility at Foret.
- $0.2 million of net charges primarily representing adjustments related to previously recorded restructuring reserves.

#### Other charges (income), net

- Corporate net charges of $9.7 million relating to environmental remediation at operating sites.
- A $5.7 million charge related to our Agricultural Products segment acquiring certain rights relating to a herbicide compound still under development.
- $1.5 million of net charges primarily related to a legal settlement associated with the U.S. hydrogen peroxide matter in our Industrial Chemicals segment.
- $0.5 million of charges in our Agricultural Products segment related to a collaboration and license agreement with a third-party company.
- $1.3 million of charges relating to the accrual of interest associated with a European Commission fine currently being appealed.
- $0.9 million of other net charges primarily adjustments related to previously recorded restructuring reserves.

The restructuring and other charges (income) of $84.9 million recorded in the nine months ended September 30, 2009, were a result of the following:

#### Restructuring charges and asset impairments

- A $1.5 million charge in our Agricultural Products segment due to our decision to phase-out operations at our Baltimore, Maryland agricultural chemicals facility. The charge consisted of (i) demolition costs of $1.0 million and (ii) other shutdown costs of $0.5 million. We ceased production at this facility in the second quarter of 2008.
- A $9.9 million charge in our Specialty Chemicals segment due to the realignment of our BioPolymer alginates manufacturing operations. The charge consisted of (i) accelerated depreciation on fixed assets to be abandoned of $6.5 million, (ii) severance and employee benefits of $3.2 million and (iii) other shut down charges of $0.2 million.
- A $7.6 million charge in our Specialty Chemicals segment due to our decision to close our Bayport butyllithium facility located in Bayport, Texas. The charge consisted of (i) accelerated depreciation on fixed assets to be abandoned of $6.9 million, and (ii) severance and employee benefits of $0.7 million.
- An $18.0 million charge in our Industrial Chemicals segment due to our decision to phase out operations of our Barcelona, Spain facility. The charge consisted of (i) severance and employee benefits of $10.3 million and (ii) accelerated depreciation on fixed assets to be abandoned of $7.7 million.
- A $6.6 million charge in our Industrial Chemicals segment due to our decision to shut down our manufacturing operations at our Peroxygens facility in Santa Clara, Mexico. The charge consisted of (i) accelerated depreciation on fixed assets to be abandoned of $3.4 million, (ii) severance and employee benefits of $1.5 million and (iii) other shut down costs of $1.7 million.
- $11.6 million of severance costs due to other workforce restructurings, of which $9.5 million related to our Industrial Chemicals segment and $2.1 million related to our Specialty Chemicals segment.
- Other asset abandonment charges of $6.8 million, of which $2.6 million related to our Agricultural Products segment, $2.6 million related to our Industrial Chemicals segment and $1.6 million related to our Specialty Chemicals segment.
- $0.4 million of other charges primarily related to adjustments to previously recorded restructuring reserves

#### Other charges (income), net

- A $2.3 million net gain as a result of exiting our lease at our Princeton facility.
- A gain of $1.0 million as a result of the sale of our sodium sulfate co-generation facility.
- A charge of $21.0 million related to the resolution of a regulatory matter in our Industrial Chemicals segment.
- A corporate net gain of $0.9 million representing recoveries partially offset by charges relating to environmental remediation at operating sites.
- Charges of $2.0 million related to our Agricultural Products segment acquiring further rights under a collaboration and license agreement with a third-party company.
- $2.6 million of charges relating to settlements with state authorities for property claims.
- $1.1 million of other net charges, primarily relating to the accrual of interest associated with a European Commission fine currently being appealed and adjustments related to previously recorded restructuring reserves.

*Purchase accounting inventory fair value impact and other inventory related adjustments* for the nine months ended September 30, 2009, represents $1.8 million in charges related to amortization of the inventory fair value step-up resulting from the application of purchase accounting associated with the third quarter 2008 acquisition in our Specialty Chemicals segment and the first quarter 2009 acquisition in our Agricultural Products segment. Additionally the amount in 2009 includes $2.9 million of inventory adjustments related to the third quarter 2008 acquisition in our Specialty Chemicals segment and subsequent alginates business restructuring. On the condensed consolidated statements of income these charges are included in “Costs of sales and services”. No such event occurred in the nine months ended September 30, 2010.

#### Provision for income taxes

We recorded a provision of $106.8 million for the first nine months of 2010 compared to a provision of $74.2 million for the prior year period resulting in effective tax rates of 29.1 percent and 28.3 percent, respectively. The change in the effective tax rate was a result of a charge in 2009 related to the resolution of a regulatory matter in our Industrial Chemicals segment that is nondeductible for tax purposes. No such event occurred in the nine months ended September 30, 2010. This was offset by a reduction in our liability in 2009 for unrecognized tax benefits of approximately $18 million as a result of settlements of audits and expiration of statute of limitations. The effective tax rate was also impacted by a tax adjustment of $3.5 million recorded during the first quarter of 2010, due to a charge associated with a change in the tax treatment of the Medicare Part D subsidy which was enacted as part of the recent U.S. health care reform legislation.

#### Discontinued operations, net of income taxes

Discontinued operations, net of income taxes totaled a loss of $25.3 million for the nine months ended September 30, 2010, compared to a loss of $15.7 million for the nine months ended September 30, 2009. The loss for the nine months ended September 30, 2010, primarily related to an increase in the provision for environmental issues at our Middleport site as well as operating and maintenance activities and charges for legal reserves and expenses related to discontinued operations.

The loss for the nine months ended September 30, 2009, primarily related to environmental charges to increase our reserve for operating and maintenance activities and charges for legal reserves and expenses related to discontinued operations partially offset by recoveries related to our Front Royal site.

#### Net income attributable to FMC stockholders

Net income attributable to FMC stockholders increased to $226.0 million for the nine months ended September 30, 2010, from $166.4 million for the nine months ended September 30, 2009. The increase was primarily due to higher profits in all three of our segments as well as significantly lower restructuring and other charges (income). Partially offsetting this was an increase in corporate expenses, higher interest expense and higher environmental charges impacting discontinued operations.

### LIQUIDITY AND CAPITAL RESOURCES

Cash and cash equivalents at September 30, 2010 and December 31, 2009, were $267.3 million and $76.6 million, respectively. At September 30, 2010, we had total debt of $668.2 million as compared to $643.9 million at December 31, 2009. This included $535.3 million and $588.0 million of long-term debt (excluding current portions of $105.4 million and $22.5 million) at September 30, 2010 and December 31, 2009, respectively. Short-term debt, which consists solely of foreign borrowings, decreased to $27.5 million at September 30, 2010, compared to $33.4 million at December 31, 2009.

#### Domestic Credit Agreement

On August 28, 2007, we executed a new credit agreement (the “Domestic Credit Agreement”) which provided for a five-year, $600 million revolving credit facility. The borrowings from this facility are available for general corporate purposes, including issuing letters of credit up to a $300 million sub-limit. The Domestic Credit Agreement also contains an option under which, subject to certain conditions, we may request an increase in the facility to $1 billion.

Loans under the facility bear interest at a floating rate, either a base rate as defined or the applicable euro currency rate for the relevant term plus an applicable margin. At September 30, 2010, the applicable euro currency margin was 0.3 percent, subject to adjustment based on the credit rating assigned to our senior unsecured debt. At September 30, 2010, the applicable borrowing rate under our Domestic Credit Agreement was 0.7 percent per annum.

We had no borrowings under our Domestic Credit Agreement at September 30, 2010 and December 31, 2009, respectively. Letters of credit outstanding under the Domestic Credit Agreement totaled $141.0 million and $153.2 million at September 30,

2010 and December 31, 2009, respectively. As such, available funds under the Domestic Credit Agreement were $459.0 million and $446.8 million at September 30, 2010 and December 31, 2009, respectively.

#### European Credit Agreement

On December 16, 2005, our Dutch finance subsidiary executed a credit agreement (the “European Credit Agreement”) which provides for an unsecured revolving credit facility in the amount of €220 million. Borrowings may be denominated in euros or U.S. dollars. FMC and our Dutch finance subsidiary’s direct parent provide guarantees of amounts due under the European Credit Agreement. On August 13, 2010, we amended this agreement to extend its maturity to August 2012.

Loans under the European Credit Agreement bear interest at a euro currency base rate, which for loans denominated in euros is the Euro InterBank Offered Rate, and for loans denominated in dollars is London Interbank Offered Rate (“LIBOR”) in each case plus a margin. The applicable margin under our European Credit Agreement is subject to adjustment based on the credit rating assigned to our senior unsecured debt. At September 30, 2010, the applicable margin was 1.8 percent and the applicable borrowing rate under the European Credit Agreement was 2.4 percent per annum.

At September 30, 2010 and December 31, 2009, respectively, we had no revolving credit facility borrowings under the European Credit Agreement. Available funds under this facility were $297.5 million and $315.4 million at September 30, 2010 and December 31, 2009, respectively.

Among other restrictions, the Domestic Credit Agreement and the European Credit Agreement contain financial covenants applicable to FMC and its consolidated subsidiaries related to leverage (measured as the ratio of debt to adjusted earnings) and interest coverage (measured as the ratio of adjusted earnings to interest expense). Our actual leverage for the four consecutive quarters ended September 30, 2010, was 1.2 which is below the maximum leverage of 3.5. Our actual interest coverage for the four consecutive quarters ended September 30, 2010, was 15.9 which is above the minimum interest coverage of 3.5. We were in compliance with all covenants at September 30, 2010.

#### Statement of Cash Flows

*Cash provided by operating activities was $308.2 million for the first nine months of 2010.*

Income from continuing operations of $260.5 million included net charges of $16.1 million, of which $9.9 million was for non-cash asset write-downs related to the exit of various facilities announced in 2009 and $6.2 million of other facilities exit costs to be settled in cash, mainly for severance costs and lease obligations. Cash spending on restructuring and other charges in the first nine months of 2010 was $47.4 million. Also included in income from continuing operations was $9.7 million for environmental and remediation at our operating sites, which will be spent in years beyond 2010. Net cash spending on environmental remediation at our operating sites in the first nine months of 2010 was $6.3 million which was recorded against pre-existing reserves. Income from continuing operations is also adjusted for other non-cash items which include stock-based compensation expense and excess tax benefits from share-based compensation. There was a significant increase in excess tax benefits from share-based compensation because we utilized our remaining U.S. financial net operating losses in 2010. See Note 13 to our condensed consolidated financial statements for further discussion on these excess tax benefits.

Receivables were a use of cash of $68.4 million due to revenue increases in our businesses, particularly for Agricultural Products sales in Brazil where terms are significantly longer than in the rest of our businesses. Partially offsetting the higher receivables were accrued customer rebates which increased by $97.7 million due to increased sales primarily in our Agricultural Products segment. These rebates are primarily in North America and Brazil and generally settle in the fourth quarter of each year. Accounts payables also increased as a result of a higher focus on payables management.

Accrued pension and other post retirement benefits were a use of cash of $86.3 million which included a voluntary contribution to our U.S. defined benefit plan of $80 million.

*Cash provided by operating activities was $274.3 million for the first nine months of 2009.*

Income from continuing operations of $187.7 million included net charges of $62.4 million, of which $31.3 million was for non-cash asset write-downs related to the exit of various facilities announced in 2009 and $31.1 million of other facilities exit costs to be settled in cash, mainly for severance costs. Cash spending on restructuring and other charges in the first nine months of 2009 was $30.1 million. Net cash spending on environmental remediation at our operating sites in the first nine months of 2009 was $8.6 million which was recorded against pre-existing reserves.

Receivables in 2009 were a use of cash of $25.0 million as lower receivables in Industrial Chemicals due to the revenue decline were more than offset by increased receivables in Agricultural Products in Brazil, where sales have grown and terms are significantly longer. Partially offsetting the higher receivables were accrued customer rebates which increased by $71.2 million due to increased sales primarily in our Agricultural Products segment. Accounts payable were a use of cash of $103.2 million as the higher cost phosphate rock in payables at the end of 2008 was replaced with lower cost phosphate rock in 2009.

Accrued pension and other post retirement benefits were a use of cash of $86.1 million which included a voluntary contribution to our U.S. defined benefit plan of $75 million.

*Cash required by operating activities of discontinued operations was $23.4 million and $31.1 million for the first nine months of 2010 and 2009, respectively.*

This change was primarily due to decreased net environmental spending in the nine months ended September 30, 2010, compared to the prior year period.

*Cash required by investing activities was $107.3 million and $141.2 million for the first nine months of 2010 and 2009, respectively.*

The change was driven primarily by the absence of acquisitions and a reduction in capital expenditures during the nine months ended September 30, 2010, as compared to the same period in 2009.

*Cash provided by financing activities was $13.3 million for the first nine months of 2010 compared to cash required of $96.5 million for the first nine months of 2009.*

This change is due primarily to lower repayments under our committed credit facilities and the inclusion of excess tax benefits from share-based compensation partially offset by a decrease in short-term debt during the nine months ended September 30, 2010.

### Other potential liquidity needs

Our cash needs for 2010 include operating cash requirements, capital expenditures, scheduled mandatory payments of long-term debt, dividend payments, contributions to our pension plans, environmental spending and restructuring. We plan to meet our liquidity needs through available cash, cash generated from operations and borrowings under our committed revolving credit facilities. We continually evaluate our options for divesting real estate holdings and property, plant and equipment that are no longer integral to any of our core operating businesses.

Projected 2010 capital expenditures are expected to be approximately 13 percent lower than 2009 levels.

Projected 2010 spending includes approximately $30 million of net environmental remediation spending. This spending does not include expected spending of approximately $9 million in 2010 on capital projects relating to environmental control facilities. Also, we expect to spend approximately $26 million in 2010 for environmental compliance costs, which we will include as a component of costs of sales and services in our condensed consolidated statements of income since these amounts are not covered by established reserves. Capital spending to expand, maintain or replace equipment at our production facilities may trigger requirements for upgrading our environmental controls, which may increase our spending for environmental controls above the foregoing projections.

During 2008, the world equity markets were down significantly, exemplified by the S&P 500 index in the U.S. being down 37 percent. Our U.S. qualified defined benefit pension plan (“U.S. Plan”) assets fell from $829.4 million at December 31, 2007 to $563.9 million at December 31, 2008. These same equity markets rebounded significantly in 2009, exemplified by the S&P 500 index in the U.S. being up 26 percent. As a result our U.S. Plan assets increased to $708.4 million at December 31, 2009. Our U.S. Plan assets comprise approximately 93 percent of our total plan assets with the difference representing plan assets related to foreign pension plans. We have reduced our expected return on our U.S. Plan assets from 8.75 percent in 2008 to 8.5 percent in 2009 and have maintained the 8.5 percent assumption in 2010. In developing the assumption for the long-term rate of return on assets for our U.S. Plan, we take into consideration the technical analysis performed by our outside actuaries, including historical market returns, information on the assumption for long-term real returns by asset class, inflation assumptions, and expectations for standard deviation related to these best estimates. We also consider the historical performance of our own plan’s trust, which has earned a compound annual rate of return of approximately 9.71 percent over the last 20 years (which is in excess of comparable market indices for the same period) as well as other factors. Given an actively managed investment portfolio, the expected annual rates of return by asset class for our portfolio, using geometric averaging, and after being adjusted for an estimated inflation rate of approximately 2.50 percent, is between 8.25 percent and 10.25 percent for equities, and between 4.75 percent and 6.0 percent for fixed-income investments, which generates a total expected portfolio return that is in line with our assumptions for the rate of return on assets. Under The Pension Protection Act of 2006, we are not required to make a minimum level of funding into the U.S. Plan during 2010, however, in order to reduce future funding volatility we contributed $80 million in 2010 versus $75 million contributed in 2009 and $30 million contributed in 2008. We do not believe that the additional contribution will have a significant negative impact on our current and future liquidity needs. However a continuation of the volatility of interest rates and negative equity returns under current market conditions may require greater contributions to the Plan in the future.

On October 21, 2010, we paid dividends totaling $9.1 million to our shareholders of record as of September 30, 2010. This amount is included in “Accrued and other liabilities” on the condensed consolidated balance sheets as of September 30, 2010.

In April 2007, the Board of Directors authorized the repurchase of up to $250 million of our common stock. In October 2008, the Board authorized the repurchase of up to an additional $250 million of our common stock. The repurchase program does not include a specific timetable or price targets and may be suspended or terminated at any time. Shares may be purchased through open market or privately negotiated transactions at the discretion of management based on its evaluation of market conditions and other factors. During the nine months ended September 30, 2010, we repurchased 565,716 shares under the publicly announced repurchase program for $35 million. The remaining dollar value of shares that may yet be purchased under this program was $155 million at September 30, 2010. We intend to repurchase up to $100 million of our common stock in the fourth quarter of 2010. We also reacquire shares from time to time from employees for taxes owed in connection with the vesting and exercise of awards under our equity compensation plans.

On July 21, 2010, the Dodd-Frank Wall Street Reform and Consumer Protection Act was signed into law. Title VII of the Act contains significant changes in the ways derivatives are regulated. Several U.S. government regulatory agencies and departments are charged with developing, largely within 360 days of passage, the many regulations required under the new law. While the exact effects on FMC cannot be known until final regulations are promulgated, we believe the liquidity requirements will be adequately met by the sources available to us.

### Commitments

We provide guarantees to financial institutions on behalf of certain Agricultural Products customers, principally in Brazil, for their seasonal borrowing. The total of these guarantees was $18.4 million and $49.5 million at September 30, 2010 and December 31, 2009, respectively, and are recorded on the condensed consolidated balance sheets for each date as “Guarantees of vendor financing”. The higher level of guarantees at December 31, 2009 compared with September 30, 2010 arose from a greater borrowing need of our Brazilian sugar cane customers in 2009.

We guarantee repayment of some of the borrowings of certain foreign affiliates accounted for using the equity method for investments. We also guarantee the repayment of the borrowing of a minority partner in a foreign affiliate that we consolidate in our financial statements. As of September 30, 2010, these guarantees had maximum potential payments of $3.5 million as compared to $5.8 million as of December 31, 2009.

Short-term debt consisted of foreign credit lines at September 30, 2010 and December 31, 2009. We provide parent-company guarantees to lending institutions providing credit to our foreign subsidiaries.

In connection with our property and asset sales and divestitures, we have agreed to indemnify the buyer for certain liabilities, including environmental contamination and taxes that occurred prior to the date of sale. Our indemnification obligations with respect to these liabilities may be indefinite as to duration and may or may not be subject to a deductible, minimum claim amount or cap. As such, it is not possible for us to predict the likelihood that a claim will be made or to make a reasonable estimate of the maximum potential loss or range of loss. If triggered, we may be able to recover certain of the indemnity payments from third parties. We have not recorded any specific liabilities for these guarantees.

### Contingencies

On January 28, 2005, we and our wholly owned subsidiary Foret received a Statement of Objections from the European Commission concerning alleged violations of competition law in the hydrogen peroxide business in Europe during the period 1994 to 2001. All of the significant European hydrogen peroxide producers also received the Statement of Objections. We and Foret responded to the Statement of Objections in April 2005 and a hearing on the matter was held at the end of June 2005. On May 3, 2006, we received a notice from the European Commission indicating that the Commission had imposed a fine on us and Foret in the aggregate amount of €25.0 million as a result of alleged violations during the period 1997-1999. In connection with this fine, we recorded an expense of $30.0 million (reflecting then-prevailing exchange rates) in our consolidated statements of income for the year ended December 31, 2006. This expense was included as a component of “Restructuring and other charges (income)”. Since we are not required to make the payment during the appeal process, the liability has been classified as long-term in the condensed consolidated balance sheets as of September 30, 2010 and December 31, 2009. Both we and Foret have appealed the decision of the Commission. The Foret appeal was argued before the Court of First Instance on March 4, 2010, but no decision has been rendered. The FMC appeal was argued in May of 2010. During the appeal process, interest accrues on the fine at a rate, which as of September 30, 2010, was 4.0 percent per annum. We have provided a bank letter of credit in favor of the European Commission to guarantee our payment of the fine and accrued interest. At September 30, 2010, the amount of the letter of credit was €30.5 million (U.S. $41.2 million).

In February 2005, putative direct and indirect purchaser class action complaints were filed against six U.S. hydrogen peroxide producers (and certain of their foreign affiliates) in various federal courts alleging violations of antitrust laws. Related cases were also filed in various state courts. In January 2009, FMC reached an agreement to settle with the direct purchaser class for $10 million, with a pro rata credit for opt outs. The $10 million figure was included as a component of “Restructuring and other charges (income)” in our consolidated statements of income for the year ended December 31, 2008. Ten companies (predominantly paper producers) opted out of this class settlement. FMC settled with two of the ten for an amount within the opt out credit described above. The remaining eight opt outs filed suit against FMC and, in some cases, Foret. These cases were assigned to the same judge as the class action. FMC’s motion to dismiss the opt out claims to the extent they were based on foreign purchases was granted on April 1, 2010. FMC has settled the remaining claims of these eight opt outs for $1.7 million which is net of a $0.3 million opt out credit. Another individual opt out case was dismissed following the bankrupt opt out’s decision to participate in the class settlement. FMC settled the indirect purchaser class claims for $0.25 million. The settlement has been preliminarily approved by the Court. All remaining state court cases will be dismissed following final approval of the indirect purchaser settlement. We recorded the $2.0 million as a component of “Restructuring and other charges (income)” in our condensed consolidated statements of income for the nine months ended September 30, 2010. In addition, putative class actions against the six major hydrogen peroxide producers have been filed in provincial courts in Ontario, Quebec and British Columbia under the laws of Canada. Four of the defendants have settled these claims for a total of approximately $20.5 million. On September 28, 2009, the Ontario Superior Court of Justice certified a class of direct and indirect purchasers of hydrogen peroxide. FMC moved for leave to appeal the class certification decision, which was denied in June 2010. The Company intends to defend these cases.

We have certain other contingent liabilities arising from litigation, claims, performance guarantees and other commitments incident to the ordinary course of business. Based on information currently available and established reserves the ultimate resolution of our known contingencies, including the matters described in Note 17 to our condensed consolidated financial statements included in this Form 10-Q, is not expected to have a material adverse effect on our consolidated financial position or liquidity. However, there can be no assurance that the outcome of these contingencies will be favorable, and adverse results in certain of these contingencies could have a material adverse effect on our consolidated financial position, results of operations or liquidity.

### Climate Change

A detailed discussion on climate change can be found in Part II, Item 7 of our 2009 consolidated financial statements on our 2009 10-K. There have been no material changes to climate change from the information reported therein.

### Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

### DERIVATIVE FINANCIAL INSTRUMENTS AND MARKET RISKS

Our earnings, cash flows, and financial position are exposed to market risks relating to fluctuations in commodity prices, interest rates and foreign currency exchange rates. Our policy is to minimize exposure to our cash flow over time caused by changes in commodity, interest and currency exchange rates. To accomplish this we have implemented a controlled program of risk management consisting of appropriate derivative contracts entered into with major financial institutions.

The analysis below presents the sensitivity of the market value of our financial instruments to selected changes in market rates and prices. The range of changes chosen reflects our view of changes that are reasonably possible over a one-year period. Market-value estimates are based on the present value of projected future cash flows considering the market rates and prices chosen.

At September 30, 2010, our net financial instrument position was a net liability of $12.2 million compared to a net asset of $0.3 million at December 31, 2009. The change in the net financial instrument position was primarily due to higher unrealized losses in our commodity and foreign exchange portfolios.

### Commodity Price Risk

Energy costs are approximately 11 percent of our cost of sales and services and are well balanced among coal, electricity, and natural gas. We attempt to mitigate our exposure to increasing energy costs by hedging the cost of future deliveries of natural gas and by entering into fixed-price contracts for the purchase of coal and fuel oil. To analyze the effect of changing energy prices, we have performed a sensitivity analysis in which we assume an instantaneous 10 percent change in energy market prices from their levels at September 30, 2010 and December 31, 2009, with all other variables (including interest rates) held constant. A 10 percent increase in energy market prices would result in a decrease in the net liability position of $4.0 million at September 30, 2010, and an increase in the net asset position of $5.1 million at December 31, 2009. A 10 percent decrease in energy market prices would result in an increase in the net liability position of $4.0 million at September 30, 2010, and a decrease in the net asset position of $7.0 million at December 31, 2009. As a result, at December 31, 2009, the net asset position would have become a net liability position.

In the second quarter of 2010, our Agricultural Products segment began entering into contracts with certain customers in Brazil to exchange our products for future physical delivery of soybeans. To mitigate the price risk associated with these barter contracts, we enter into offsetting derivatives to hedge our exposure. As of September 30, 2010 and December 31, 2009, we had no such contracts in place.

### Foreign Currency Exchange Rate Risk

The primary currencies for which we have exchange rate exposure are the U.S. dollar versus the euro, the U.S. dollar versus the Chinese yuan and the U.S. dollar versus the Brazilian real. Foreign currency debt and foreign exchange forward contracts are used in countries where we do business, thereby reducing our net asset exposure. Foreign exchange forward contracts are also used to hedge firm and highly anticipated foreign currency cash flows.

To analyze the effects of changing foreign currency rates, we have performed a sensitivity analysis in which we assume an instantaneous 10 percent change in the foreign currency exchange rates from their levels at September 30, 2010 and December 31, 2009, with all other variables (including interest rates) held constant. A 10 percent strengthening of the hedged currencies versus our functional currencies would result in a decrease of the net liability position of $0.9 million at September 30, 2010, and an increase in the net liability position of $17.5 million at December 31, 2009. A 10 percent weakening of the hedged currencies versus our functional currencies would result in an increase of the net liability position of $2.3 million at September 30, 2010 and a decrease in the net liability position of $17.8 million at December 31, 2009. As a result, at December 31, 2009, the net liability position would have become a net asset position.

### Interest Rate Risk

We use various strategies to manage our interest rate exposure, including entering into interest rate swap agreements. As of September 30, 2010 and December 31, 2009, we had no agreements in place.

Our debt portfolio, at September 30, 2010, is composed of 91 percent fixed-rate debt and nine percent variable-rate debt. The variable-rate component of our debt portfolio principally consists of borrowings under our Domestic and European Credit Agreements, variable-rate industrial and pollution control revenue bonds, and foreign bank borrowings. Changes in interest rates affect different portions of our variable-rate debt portfolio in different ways.

Based on the variable-rate instruments in our debt portfolio at September 30, 2010, a one percentage point increase in interest rates would raise interest costs by $0.5 million for the first nine months of the year and a one percentage point decrease in interest rates then in effect would have reduced interest expense by $0.3 million for the first nine months of the year.

## Market risk

As filed, 207 characters.

The information required by this item is provided in “Derivative Financial Instruments and Market Risks,” under ITEM 2 - Management’s Discussion and Analysis of Financial Condition and Results of Operations.

## Controls and procedures

As filed, 3,522 characters.

(a) Evaluation of disclosure controls and procedures. Based on management’s evaluation (with the participation of the Company’s Chief Executive Officer and Chief Financial Officer), the Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of the period covered by this report, the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) are effective to provide reasonable assurance that information required to be disclosed by the Company in reports filed or submitted under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and is accumulated and communicated to management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

(b) Change in Internal Controls. There have been no changes in internal control over financial reporting that occurred during the quarter ended September 30, 2010, that materially affected or are reasonably likely to materially affect, our internal control over financial reporting.

### REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

#### Report of Independent Registered Public Accounting Firm

The Board of Directors

FMC Corporation:

We have reviewed the condensed consolidated balance sheet of FMC Corporation and subsidiaries as of September 30, 2010, the related condensed consolidated statements of income for the three and nine months ended September 30, 2010 and 2009 and the condensed consolidated statements of cash flows for the nine months ended September 30, 2010 and 2009. These condensed consolidated financial statements are the responsibility of the Company’s management.

We conducted our reviews in accordance with the standards of the Public Company Accounting Oversight Board (United States). A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States), the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.

Based on our reviews, we are not aware of any material modifications that should be made to the condensed consolidated financial statements referred to above for them to be in conformity with U.S. generally accepted accounting principles.

We have previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheet of FMC Corporation and subsidiaries as of December 31, 2009, and the related consolidated statements of income, changes in equity, cash flows and comprehensive income for the year then ended (not presented herein) and in our report dated February 22, 2010, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying condensed consolidated balance sheet as of December 31, 2009, is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.

### /s/ KPMG LLP

Philadelphia, Pennsylvania

November 2, 2010

Filed Nov 2, 2010.
Source: SEC EDGAR, the filing index for accession 0001193125-10-244206. Last ingested by Listed: Nov 13, 2026, 16:31 ET. No prices; not investment advice.
